BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 7
• 8
• 9
• 10
• 11
• 14
• 15
• 16
• 17
• 18
• 21
• 22
• 23
• 28
• 29
• 30

• FDA

  Par Pharmaceutical Companies, Inc. Receives Approval And Marketing Exclusivity For Ondanestron Hydrochloride Orally Disintegrating Tablets

  November 21, 2005

   · 

  2 min read
• Business

  Endosense Completes CHF 26 Million ($20 Million) Fundraising Backed By 3i And NeoMed

  November 21, 2005

   · 

  1 min read
• Drug Development

  Ascenta Therapeutics Inc. AT-101 Clinical Trial Data Presented At The AACR-NCI-EORTC International Conference On Molecular Targets And Cancer Therapeutics In Philadelphia, Pennsylvania

  November 21, 2005

   · 

  1 min read
• Drug Development

  Futura Medical Says Trial Results For Erectile Dysfunction Gel ‘Encouraging’

  November 21, 2005

   · 

  1 min read
• Business

  The U. S. FDA To Use IMMD’s KeyMolnet By integration With FDA’s ArrayTrack System For Reviewing Pharmacogenomic Data

  November 21, 2005

   · 

  1 min read
• Drug Development

  Roche Release: Zyvex FDA Advisory Committee Affirms Safety Of Tamiflu In Children

  November 21, 2005

   · 

  6 min read
• Solvay Pharmaceuticals, Inc. And Chemical Products Corporation Launch Global Barium Strontium Joint Venture

  November 21, 2005

   · 

  1 min read
• Genetown

  FDA And Biogen Idec, Inc. (BIIB) Warn Not To Take Amevive With HIV

  November 21, 2005

   · 

  1 min read
• Policy

  BioMimetic Therapeutics Announces FDA Approval Of GEM 21S(R) Growth-Factor Enhanced Matrix For The Treatment Of Periodontally-Related Bone Defects

  November 21, 2005

   · 

  1 min read
• FDA

  Wyeth Release: EFFEXOR XR Approved For The Treatment Of Panic Disorder

  November 21, 2005

   · 

  4 min read